Literature DB >> 25498084

Severe veno-occlusive disease/sinusoidal obstruction syndrome after deceased-donor and living-donor liver transplantation.

H Takamura1, S Nakanuma1, H Hayashi1, H Tajima1, K Kakinoki2, M Kitahara2, S Sakai1, I Makino1, H Nakagawara1, T Miyashita1, K Okamoto1, K Nakamura1, K Oyama1, M Inokuchi1, I Ninomiya1, H Kitagawa1, S Fushida1, T Fujimura1, I Onishi1, M Kayahara1, T Tani1, K Arai2, Taro Yamashita2, Tatsuya Yamashita2, H Kitamura3, H Ikeda4, S Kaneko2, Y Nakanuma3, O Matsui5, T Ohta1.   

Abstract

Veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) occurring after liver transplantation is a relatively rare complication but it often takes a life-threatening course. However, the detailed etiology and mechanism of VOD/SOS after liver transplantation (LT) remains unclear. We report two cases with rapidly progressive VOD/SOS after ABO-identical LT resistant to various therapies. In case 1, in which the patient underwent deceased-donor LT, the first episode of acute allograft rejection was triggered VOD/SOS, and the presence of donor non-specific anti-HLA antibodies was confirmed. The recipient died with graft failure on day 46 after transplantation. Case 2, in which the patient underwent living-donor LT from the mother, had neither rejection nor mechanical venous obstruction, but condition of the patient rapidly worsened and he died on day 13 after transplantation. This recipient's direct cross-match test for the donor's B lymphocyte was strongly positive, but that for T lymphocyte was negative. In both cases, neither stenosis of hepatic vein outflow tract nor C4d deposition in post-transplantation liver biopsy specimens and autopsy specimen was found. On the other hand, in both cases, the patient was transfusion unresponsive thrombocytopenia and hyperbilirubinemia persisted postoperatively, and glycoprotein Ⅰ bα was strongly stained in the neighboring centrilobular area (zone 3), especially in the space of Disse, and platelet phagocytosis was observed in Kupffer cells and hepatocytes around zone 3 such as clinical xenotransplantation of the liver in post-transplantation liver biopsy specimens. From the viewpoint of graft injury, VOD/SOS was considered that sustained sinusoidal endothelial cells injury resulted in bleeding in the space of Disse and led to around centrilobular hemorrhagic necrosis, and the fundamental cause was damage around centrilobular area including sinusoid by acute cellular rejection, antibody-mediated rejection or ischemic reperfusion injury. The extrasinusoidal platelet activation, aggregation, and phagocytosis of platelets were some of the main reasons for VOD/SOS and transfusion-resistant thrombocytopenia.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25498084     DOI: 10.1016/j.transproceed.2014.09.110

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  8 in total

1.  Prophylactic Effect of Recombinant Human Soluble Thrombomodulin for Hepatic Sinusoidal Obstruction Syndrome Model Mice.

Authors:  Shunsuke Kanou; Tomoharu Miyashita; Yasuhiko Yamamoto; Satoshi Takada; Makoto Nakura; Mitsuyoshi Okazaki; Yoshinao Ohbatake; Shinichi Nakanuma; Isamu Makino; Hidehiro Tajima; Hiroyuki Takamura; Sachio Fushida; Tetsuo Ohta
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Inferior vena cava stenosis-induced sinusoidal obstructive syndrome after living donor liver transplantation.

Authors:  Batsaikhan Bat-Erdene; Sergelen Orgoi; Erdene Sandag; Ulzii-Orshikh Namkhai; Bat-Ireedui Badarch; Batsaikhan Batsuuri
Journal:  Korean J Hepatobiliary Pancreat Surg       Date:  2016-08-29

3.  Soluble Thrombomodulin Attenuates Endothelial Cell Damage in Hepatic Sinusoidal Obstruction Syndrome.

Authors:  Satoshi Takada; Tomoharu Miyashita; Yasuhiko Yamamoto; Shunsuke Kanou; Seiichi Munesue; Yoshinao Ohbatake; Shinichi Nakanuma; Koichi Okamoto; Seisho Sakai; Jun Kinoshita; Isamu Makino; Keishi Nakamura; Hidehiro Tajima; Hiroyuki Takamura; Itasu Ninomiya; Sachio Fushida; Tetsuo Ohta
Journal:  In Vivo       Date:  2018 Nov-Dec       Impact factor: 2.155

4.  Pretreatment with a Phosphodiesterase-3 Inhibitor, Milrinone, Reduces Hepatic Ischemia-Reperfusion Injury, Minimizing Pericentral Zone-Based Liver and Small Intestinal Injury in Rats.

Authors:  Shinichi Nakanuma; Hidehiro Tajima; Hiroyuki Takamura; Seisho Sakai; Ryosuke Gabata; Mitsuyoshi Okazaki; Hiroyuki Shinbashi; Yoshinao Ohbatake; Isamu Makino; Hironori Hayashi; Tomoharu Miyashita; Sachio Fushida; Tetsuo Ohta
Journal:  Ann Transplant       Date:  2020-07-14       Impact factor: 1.530

Review 5.  Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Francesca Bonifazi; Francesco Barbato; Federico Ravaioli; Mariarosaria Sessa; Irene Defrancesco; Mario Arpinati; Michele Cavo; Antonio Colecchia
Journal:  Front Immunol       Date:  2020-04-03       Impact factor: 7.561

Review 6.  Ischemia reperfusion-facilitated sinusoidal endothelial cell injury in liver transplantation and the resulting impact of extravasated platelet aggregation.

Authors:  T Miyashita; S Nakanuma; A K Ahmed; I Makino; H Hayashi; K Oyama; H Nakagawara; H Tajima; H Takamura; I Ninomiya; S Fushida; J W Harmon; T Ohta
Journal:  Eur Surg       Date:  2015-10-14       Impact factor: 0.953

Review 7.  Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review.

Authors:  Yuchen Hou; Nga Lei Tam; Zhicheng Xue; Xuzhi Zhang; Bing Liao; Jie Yang; Shunjun Fu; Yi Ma; Linwei Wu; Xiaoshun He
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

8.  Successful defibrotide treatment of a patient with veno-occlusive disease after living-donor liver transplantation: A case report.

Authors:  Tae Beom Lee; Kwangho Yang; Hyo Jung Ko; Jae Ryong Shim; Byung Hyun Choi; Jung Hee Lee; Je Ho Ryu
Journal:  Medicine (Baltimore)       Date:  2021-06-25       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.